+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 65Years
All Genders
Healthy Volunteers
ID04086329

Testing a New Minimally Invasive Nanosensor to Measure Mitochondrial Function in Adults with Mitochondrial Myopathy

Led by Children's Hospital of Philadelphia · Updated on 2026-02-18

24

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying mitochondrial myopathy MM, a condition where mitochondrial function in muscle tissue is impaired. This investigational device trial aims to evaluate an electrochemical oxygen nanosensors ability to measure mitochondrial function in human muscle and to distinguish MM patients from healthy volunteers. The study is motivated by the need for reliable biomarkers to assess MM severity, progression, and response to treatment. The study involves placing a small nanosensor device into the dominant forearm muscle under local anesthesia. Participants will perform handgrip exercises while the device measures oxygen levels in the muscle. These measurements will be taken at two visits spaced 7 to 30 days apart to check for consistency. The study includes two groups adults aged 18 to 65 with genetically confirmed MM and matched healthy volunteers. Participants will undergo muscle oxygen level measurements during exercise, with data collected for up to 60 minutes at each visit. Researchers will also assess pain and tolerability associated with the nanosensor placement. The total study duration spans up to 6 months, including the two measurement visits. The study will help determine the devices reproducibility and potential use in future mitochondrial disease research.

CONDITIONS

Brief Title

Validation of Oxygen Nanosensor in Mitochondrial Myopathy

Research Team

Z

Zarazuela Zolkipli-Cunningham

S

Sara Nguyen

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here